Immunoglobulin G3 antibodies specific for the 19-kilodalton carboxyl- terminal fragment of Plasmodium yoelii merozoite surface protein 1 transfer protection to mice deficient in Fc-γRI receptors

Infection and Immunity

Volumn 68, Issue 5, 2000, Pages 3019-3022

  Vukovic, Peter ^a   Hogarth, P Mark ^b   Barnes, Nadine ^b   Kaslow, David C ^c,d   Good, Michael F ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b AUSTIN RESEARCH INSTITUTE   (Australia)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; IMMUNOGLOBULIN G ANTIBODY; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; MEROZOITE; MOUSE; NONHUMAN; PARASITEMIA; PASSIVE IMMUNIZATION; PHAGOCYTOSIS; PLASMODIUM YOELII; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, PROTOZOAN; ANTIBODY SPECIFICITY; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MALARIA; MEROZOITE SURFACE PROTEIN 1; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE FRAGMENTS; PLASMODIUM YOELII; RECEPTORS, IGG;

EID: 0034059120     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.5.3019-3022.2000     Document Type: Article

References (19)

1. Blackman, M. J., T. J. Scott-Finnigan, S. Shai, and A. A. Holder. 1994. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180:389-393.
2. Cohen, S., I. A. McGregor, and S. Carrington. 1961. Gamma-globulin and acquired immunity to human malaria. Nature 192:733-737.
3. Daly, T. M., and C. A. Long. 1993. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect. Immun. 61: 2462-2467.
4. 3. J. Exp. Med. 153:514-519.
5. Druilhe, P., and J. L. Perignon. 1994. Mechanisms of defence against P. falciparum asexual blood stages in humans. Immunol. Lett. 41:115-120.
6. Epstein, N., L. H. Miller, D. C. Kaushel, I. J. Udeinya, J. Rener, R. J. Howard, R. Asofsky, M. Aikawa, and R. L. Hess. 1981. Monoclonal antibodies against a specific surface determinant on malarial (Plasmodium knowlesi) merozoites block erythrocyte invasion. J. Immunol. 127:212-217.
7. Gavin, A. L., N. Barnes, H. M. Dijstelbloem, and P. M. Hogarth. 1998. Identification of the mouse IgG3 receptor: implications for antibody effector function at the interface between innate and adaptive immunity. J. Immunol. 160:20-23.
8. 19) of Plasmodium yoelii expressed in Saccharomyces cerevisiae. J. Immunol. 159:3400-3411.
9. Hirunpetcharat, C., P. Vukovic, X. Q. Liu, D. C. Kaslow, L. H. Miller, and M. F. Good. 1999. Absolute requirement for an active immune response involving B cells and Th cells in immunity to Plasmodium yoelii passively acquired with antibodies to the 19-kDa carhoxyl-terminal fragment of merozoite surface protein-1. J. Immunol. 162:7309-7314.
10. Kumar, S., A. Yadavam, D. B. Keister, J. H. Tian, M. Ohl, K. A. Perdue-Greenfield, L. H. Miller, and D. C. Kaslow. 1995. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:325-332.
11. Ling, I. T., S. A. Ogun, and A. A. Holder. 1994. Immunization against malaria with a recombinant protein. Parasite Immunol. 16:63-67.
12. Ling, I. T., S. A. Ogun, P. Momin, R. L. Richards, N. Garcon, J. Cohen, W. R. Ballou, and A. A. Holder. 1997. Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use. Vaccine 15:1562-1567.
13. Quinn, T. C., and D. J. Wyler. 1979. Mechanisms of action of hyperimmune serum in mediating protective immunity to rodent malaria (Plasmodium berghei). J. Immunol. 123:2245-2249.
14. Ravetch, J. V., and R. A. Clynes. 1998. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16:421-432.
15. Rotman, H. L., T. M. Daly, R. Clynes, and C. A. Long. 1998. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model. J. Immunol. 161:1908-1912.
16. Stoute, J. A., M. Slaoui, D. G. Heppner, P. Momin, K. E. Kester, P. Desmons, B. T. Wellde, N. Garcon, U. Krzych, and M. Marchand. 1997. A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group. N. Engl. J. Med. 336:86-91.
17. Takai, T., M. Li, D. Sylvestre, R. Clynes, and J. V. Ravetch. 1994. FcRγ chain deletion results in pleiotrophic effector cell defects. Cell 76:519-529.
18. Tian, J. H., L. H. Miller, D. C. Kaslow, J. Ahlers, M. F. Good, D. W. Alling, J. A. Berzofsky, and S. Kumar. 1996. Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine. J. Immunol. 157:1176-1183.
19. Yuan, R., R. Clynes, J. Oh, J. V. Ravetch, and M. D. Scharff. 1998. Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J. Exp. Med. 187:641-648.